Sandra Bien-Möller

7PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersMolecular targetsProteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 28, 2025
Case report of three patients with end-stage recurrent glioblastoma treated with meldonium.

Sandra Bien-Möller, Martin E Weidemeier, Josefine Radke

|Sep 23, 2022
Platelet-Derived S1P and Its Relevance for the Communication with Immune Cells in Multiple Human Diseases.

Céline Tolksdorf, Eileen Moritz, Robert Wolf

|Oct 23, 2021
PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells.

Carolin Seifert, Ellen Balz, Susann Herzog

|Jan 24, 2019
L-Carnitine-Mediated Tumor Cell Protection and Poor Patient Survival Associated with OCTN2 Overexpression in Glioblastoma Multiforme.

Matthias A Fink, Heiko Paland, Susann Herzog

Pageof 2